Pharma & Healthcare
Global Chronic Hepatitis C Drug Market Research Report 2023
- Jan 18, 24
- ID: 1581
- Pages: 78
- Figures: 143
- Views: 48
According to HengCe’s new survey, global Chronic Hepatitis C Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
Key companies engaged in the Chronic Hepatitis C Drug industry include Gilead, Bristol Myers Squibb, AbbVie, Johnson & Johnson, Boehringer Ingelheim, Merck and Kawin Technology, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Chronic Hepatitis C Drug were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Chronic Hepatitis C Drug market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Chronic Hepatitis C Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Gilead
Bristol Myers Squibb
AbbVie
Johnson & Johnson
Boehringer Ingelheim
Merck
Kawin Technology
Segment by Type
Oral Drug
Injectable Drug
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chronic Hepatitis C Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Key companies engaged in the Chronic Hepatitis C Drug industry include Gilead, Bristol Myers Squibb, AbbVie, Johnson & Johnson, Boehringer Ingelheim, Merck and Kawin Technology, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Chronic Hepatitis C Drug were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Chronic Hepatitis C Drug market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Chronic Hepatitis C Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Gilead
Bristol Myers Squibb
AbbVie
Johnson & Johnson
Boehringer Ingelheim
Merck
Kawin Technology
Segment by Type
Oral Drug
Injectable Drug
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chronic Hepatitis C Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Hepatitis C Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral Drug
1.2.3 Injectable Drug
1.3 Market by Application
1.3.1 Global Chronic Hepatitis C Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Hepatitis C Drug Market Perspective (2018-2029)
2.2 Chronic Hepatitis C Drug Growth Trends by Region
2.2.1 Global Chronic Hepatitis C Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chronic Hepatitis C Drug Historic Market Size by Region (2018-2023)
2.2.3 Chronic Hepatitis C Drug Forecasted Market Size by Region (2024-2029)
2.3 Chronic Hepatitis C Drug Market Dynamics
2.3.1 Chronic Hepatitis C Drug Industry Trends
2.3.2 Chronic Hepatitis C Drug Market Drivers
2.3.3 Chronic Hepatitis C Drug Market Challenges
2.3.4 Chronic Hepatitis C Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Hepatitis C Drug Players by Revenue
3.1.1 Global Top Chronic Hepatitis C Drug Players by Revenue (2018-2023)
3.1.2 Global Chronic Hepatitis C Drug Revenue Market Share by Players (2018-2023)
3.2 Global Chronic Hepatitis C Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Hepatitis C Drug Revenue
3.4 Global Chronic Hepatitis C Drug Market Concentration Ratio
3.4.1 Global Chronic Hepatitis C Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Hepatitis C Drug Revenue in 2022
3.5 Chronic Hepatitis C Drug Key Players Head office and Area Served
3.6 Key Players Chronic Hepatitis C Drug Product Solution and Service
3.7 Date of Enter into Chronic Hepatitis C Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Hepatitis C Drug Breakdown Data by Type
4.1 Global Chronic Hepatitis C Drug Historic Market Size by Type (2018-2023)
4.2 Global Chronic Hepatitis C Drug Forecasted Market Size by Type (2024-2029)
5 Chronic Hepatitis C Drug Breakdown Data by Application
5.1 Global Chronic Hepatitis C Drug Historic Market Size by Application (2018-2023)
5.2 Global Chronic Hepatitis C Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chronic Hepatitis C Drug Market Size (2018-2029)
6.2 North America Chronic Hepatitis C Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chronic Hepatitis C Drug Market Size by Country (2018-2023)
6.4 North America Chronic Hepatitis C Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Hepatitis C Drug Market Size (2018-2029)
7.2 Europe Chronic Hepatitis C Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chronic Hepatitis C Drug Market Size by Country (2018-2023)
7.4 Europe Chronic Hepatitis C Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Hepatitis C Drug Market Size (2018-2029)
8.2 Asia-Pacific Chronic Hepatitis C Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chronic Hepatitis C Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Chronic Hepatitis C Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Hepatitis C Drug Market Size (2018-2029)
9.2 Latin America Chronic Hepatitis C Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chronic Hepatitis C Drug Market Size by Country (2018-2023)
9.4 Latin America Chronic Hepatitis C Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Hepatitis C Drug Market Size (2018-2029)
10.2 Middle East & Africa Chronic Hepatitis C Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chronic Hepatitis C Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Chronic Hepatitis C Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead
11.1.1 Gilead Company Detail
11.1.2 Gilead Business Overview
11.1.3 Gilead Chronic Hepatitis C Drug Introduction
11.1.4 Gilead Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.1.5 Gilead Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Chronic Hepatitis C Drug Introduction
11.2.4 Bristol Myers Squibb Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.2.5 Bristol Myers Squibb Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Chronic Hepatitis C Drug Introduction
11.3.4 AbbVie Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.3.5 AbbVie Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Chronic Hepatitis C Drug Introduction
11.4.4 Johnson & Johnson Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Chronic Hepatitis C Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Chronic Hepatitis C Drug Introduction
11.6.4 Merck Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Kawin Technology
11.7.1 Kawin Technology Company Detail
11.7.2 Kawin Technology Business Overview
11.7.3 Kawin Technology Chronic Hepatitis C Drug Introduction
11.7.4 Kawin Technology Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.7.5 Kawin Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Hepatitis C Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral Drug
1.2.3 Injectable Drug
1.3 Market by Application
1.3.1 Global Chronic Hepatitis C Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Hepatitis C Drug Market Perspective (2018-2029)
2.2 Chronic Hepatitis C Drug Growth Trends by Region
2.2.1 Global Chronic Hepatitis C Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chronic Hepatitis C Drug Historic Market Size by Region (2018-2023)
2.2.3 Chronic Hepatitis C Drug Forecasted Market Size by Region (2024-2029)
2.3 Chronic Hepatitis C Drug Market Dynamics
2.3.1 Chronic Hepatitis C Drug Industry Trends
2.3.2 Chronic Hepatitis C Drug Market Drivers
2.3.3 Chronic Hepatitis C Drug Market Challenges
2.3.4 Chronic Hepatitis C Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Hepatitis C Drug Players by Revenue
3.1.1 Global Top Chronic Hepatitis C Drug Players by Revenue (2018-2023)
3.1.2 Global Chronic Hepatitis C Drug Revenue Market Share by Players (2018-2023)
3.2 Global Chronic Hepatitis C Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Hepatitis C Drug Revenue
3.4 Global Chronic Hepatitis C Drug Market Concentration Ratio
3.4.1 Global Chronic Hepatitis C Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Hepatitis C Drug Revenue in 2022
3.5 Chronic Hepatitis C Drug Key Players Head office and Area Served
3.6 Key Players Chronic Hepatitis C Drug Product Solution and Service
3.7 Date of Enter into Chronic Hepatitis C Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Hepatitis C Drug Breakdown Data by Type
4.1 Global Chronic Hepatitis C Drug Historic Market Size by Type (2018-2023)
4.2 Global Chronic Hepatitis C Drug Forecasted Market Size by Type (2024-2029)
5 Chronic Hepatitis C Drug Breakdown Data by Application
5.1 Global Chronic Hepatitis C Drug Historic Market Size by Application (2018-2023)
5.2 Global Chronic Hepatitis C Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chronic Hepatitis C Drug Market Size (2018-2029)
6.2 North America Chronic Hepatitis C Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chronic Hepatitis C Drug Market Size by Country (2018-2023)
6.4 North America Chronic Hepatitis C Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Hepatitis C Drug Market Size (2018-2029)
7.2 Europe Chronic Hepatitis C Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chronic Hepatitis C Drug Market Size by Country (2018-2023)
7.4 Europe Chronic Hepatitis C Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Hepatitis C Drug Market Size (2018-2029)
8.2 Asia-Pacific Chronic Hepatitis C Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chronic Hepatitis C Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Chronic Hepatitis C Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Hepatitis C Drug Market Size (2018-2029)
9.2 Latin America Chronic Hepatitis C Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chronic Hepatitis C Drug Market Size by Country (2018-2023)
9.4 Latin America Chronic Hepatitis C Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Hepatitis C Drug Market Size (2018-2029)
10.2 Middle East & Africa Chronic Hepatitis C Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chronic Hepatitis C Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Chronic Hepatitis C Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead
11.1.1 Gilead Company Detail
11.1.2 Gilead Business Overview
11.1.3 Gilead Chronic Hepatitis C Drug Introduction
11.1.4 Gilead Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.1.5 Gilead Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Chronic Hepatitis C Drug Introduction
11.2.4 Bristol Myers Squibb Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.2.5 Bristol Myers Squibb Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Chronic Hepatitis C Drug Introduction
11.3.4 AbbVie Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.3.5 AbbVie Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Chronic Hepatitis C Drug Introduction
11.4.4 Johnson & Johnson Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Chronic Hepatitis C Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Chronic Hepatitis C Drug Introduction
11.6.4 Merck Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Kawin Technology
11.7.1 Kawin Technology Company Detail
11.7.2 Kawin Technology Business Overview
11.7.3 Kawin Technology Chronic Hepatitis C Drug Introduction
11.7.4 Kawin Technology Revenue in Chronic Hepatitis C Drug Business (2018-2023)
11.7.5 Kawin Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Chronic Hepatitis C Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral Drug
Table 3. Key Players of Injectable Drug
Table 4. Global Chronic Hepatitis C Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Chronic Hepatitis C Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Chronic Hepatitis C Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Chronic Hepatitis C Drug Market Share by Region (2018-2023)
Table 8. Global Chronic Hepatitis C Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Chronic Hepatitis C Drug Market Share by Region (2024-2029)
Table 10. Chronic Hepatitis C Drug Market Trends
Table 11. Chronic Hepatitis C Drug Market Drivers
Table 12. Chronic Hepatitis C Drug Market Challenges
Table 13. Chronic Hepatitis C Drug Market Restraints
Table 14. Global Chronic Hepatitis C Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Chronic Hepatitis C Drug Market Share by Players (2018-2023)
Table 16. Global Top Chronic Hepatitis C Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis C Drug as of 2022)
Table 17. Ranking of Global Top Chronic Hepatitis C Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Chronic Hepatitis C Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chronic Hepatitis C Drug Product Solution and Service
Table 21. Date of Enter into Chronic Hepatitis C Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Hepatitis C Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Chronic Hepatitis C Drug Revenue Market Share by Type (2018-2023)
Table 25. Global Chronic Hepatitis C Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Chronic Hepatitis C Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Chronic Hepatitis C Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Chronic Hepatitis C Drug Revenue Market Share by Application (2018-2023)
Table 29. Global Chronic Hepatitis C Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Chronic Hepatitis C Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Chronic Hepatitis C Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Chronic Hepatitis C Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Chronic Hepatitis C Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Chronic Hepatitis C Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Chronic Hepatitis C Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Chronic Hepatitis C Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Chronic Hepatitis C Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Chronic Hepatitis C Drug Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Chronic Hepatitis C Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Chronic Hepatitis C Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Chronic Hepatitis C Drug Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Chronic Hepatitis C Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Chronic Hepatitis C Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Chronic Hepatitis C Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Chronic Hepatitis C Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Gilead Company Detail
Table 47. Gilead Business Overview
Table 48. Gilead Chronic Hepatitis C Drug Product
Table 49. Gilead Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 50. Gilead Recent Development
Table 51. Bristol Myers Squibb Company Detail
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Chronic Hepatitis C Drug Product
Table 54. Bristol Myers Squibb Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 55. Bristol Myers Squibb Recent Development
Table 56. AbbVie Company Detail
Table 57. AbbVie Business Overview
Table 58. AbbVie Chronic Hepatitis C Drug Product
Table 59. AbbVie Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 60. AbbVie Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Chronic Hepatitis C Drug Product
Table 64. Johnson & Johnson Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Boehringer Ingelheim Company Detail
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Chronic Hepatitis C Drug Product
Table 69. Boehringer Ingelheim Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Merck Company Detail
Table 72. Merck Business Overview
Table 73. Merck Chronic Hepatitis C Drug Product
Table 74. Merck Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Kawin Technology Company Detail
Table 77. Kawin Technology Business Overview
Table 78. Kawin Technology Chronic Hepatitis C Drug Product
Table 79. Kawin Technology Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 80. Kawin Technology Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Hepatitis C Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Chronic Hepatitis C Drug Market Share by Type: 2022 VS 2029
Figure 3. Oral Drug Features
Figure 4. Injectable Drug Features
Figure 5. Global Chronic Hepatitis C Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Chronic Hepatitis C Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Chronic Hepatitis C Drug Report Years Considered
Figure 11. Global Chronic Hepatitis C Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Chronic Hepatitis C Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Chronic Hepatitis C Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Chronic Hepatitis C Drug Market Share by Players in 2022
Figure 15. Global Top Chronic Hepatitis C Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis C Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Chronic Hepatitis C Drug Revenue in 2022
Figure 17. North America Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Chronic Hepatitis C Drug Market Share by Country (2018-2029)
Figure 19. United States Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Chronic Hepatitis C Drug Market Share by Country (2018-2029)
Figure 23. Germany Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Chronic Hepatitis C Drug Market Share by Region (2018-2029)
Figure 31. China Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Chronic Hepatitis C Drug Market Share by Country (2018-2029)
Figure 39. Mexico Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Chronic Hepatitis C Drug Market Share by Country (2018-2029)
Figure 43. Turkey Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Gilead Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 46. Bristol Myers Squibb Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 47. AbbVie Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 51. Kawin Technology Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Table 1. Global Chronic Hepatitis C Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral Drug
Table 3. Key Players of Injectable Drug
Table 4. Global Chronic Hepatitis C Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Chronic Hepatitis C Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Chronic Hepatitis C Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Chronic Hepatitis C Drug Market Share by Region (2018-2023)
Table 8. Global Chronic Hepatitis C Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Chronic Hepatitis C Drug Market Share by Region (2024-2029)
Table 10. Chronic Hepatitis C Drug Market Trends
Table 11. Chronic Hepatitis C Drug Market Drivers
Table 12. Chronic Hepatitis C Drug Market Challenges
Table 13. Chronic Hepatitis C Drug Market Restraints
Table 14. Global Chronic Hepatitis C Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Chronic Hepatitis C Drug Market Share by Players (2018-2023)
Table 16. Global Top Chronic Hepatitis C Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis C Drug as of 2022)
Table 17. Ranking of Global Top Chronic Hepatitis C Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Chronic Hepatitis C Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chronic Hepatitis C Drug Product Solution and Service
Table 21. Date of Enter into Chronic Hepatitis C Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Hepatitis C Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Chronic Hepatitis C Drug Revenue Market Share by Type (2018-2023)
Table 25. Global Chronic Hepatitis C Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Chronic Hepatitis C Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Chronic Hepatitis C Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Chronic Hepatitis C Drug Revenue Market Share by Application (2018-2023)
Table 29. Global Chronic Hepatitis C Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Chronic Hepatitis C Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Chronic Hepatitis C Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Chronic Hepatitis C Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Chronic Hepatitis C Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Chronic Hepatitis C Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Chronic Hepatitis C Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Chronic Hepatitis C Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Chronic Hepatitis C Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Chronic Hepatitis C Drug Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Chronic Hepatitis C Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Chronic Hepatitis C Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Chronic Hepatitis C Drug Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Chronic Hepatitis C Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Chronic Hepatitis C Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Chronic Hepatitis C Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Chronic Hepatitis C Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Gilead Company Detail
Table 47. Gilead Business Overview
Table 48. Gilead Chronic Hepatitis C Drug Product
Table 49. Gilead Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 50. Gilead Recent Development
Table 51. Bristol Myers Squibb Company Detail
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Chronic Hepatitis C Drug Product
Table 54. Bristol Myers Squibb Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 55. Bristol Myers Squibb Recent Development
Table 56. AbbVie Company Detail
Table 57. AbbVie Business Overview
Table 58. AbbVie Chronic Hepatitis C Drug Product
Table 59. AbbVie Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 60. AbbVie Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Chronic Hepatitis C Drug Product
Table 64. Johnson & Johnson Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Boehringer Ingelheim Company Detail
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Chronic Hepatitis C Drug Product
Table 69. Boehringer Ingelheim Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Merck Company Detail
Table 72. Merck Business Overview
Table 73. Merck Chronic Hepatitis C Drug Product
Table 74. Merck Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Kawin Technology Company Detail
Table 77. Kawin Technology Business Overview
Table 78. Kawin Technology Chronic Hepatitis C Drug Product
Table 79. Kawin Technology Revenue in Chronic Hepatitis C Drug Business (2018-2023) & (US$ Million)
Table 80. Kawin Technology Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Hepatitis C Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Chronic Hepatitis C Drug Market Share by Type: 2022 VS 2029
Figure 3. Oral Drug Features
Figure 4. Injectable Drug Features
Figure 5. Global Chronic Hepatitis C Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Chronic Hepatitis C Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Chronic Hepatitis C Drug Report Years Considered
Figure 11. Global Chronic Hepatitis C Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Chronic Hepatitis C Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Chronic Hepatitis C Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Chronic Hepatitis C Drug Market Share by Players in 2022
Figure 15. Global Top Chronic Hepatitis C Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis C Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Chronic Hepatitis C Drug Revenue in 2022
Figure 17. North America Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Chronic Hepatitis C Drug Market Share by Country (2018-2029)
Figure 19. United States Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Chronic Hepatitis C Drug Market Share by Country (2018-2029)
Figure 23. Germany Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Chronic Hepatitis C Drug Market Share by Region (2018-2029)
Figure 31. China Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Chronic Hepatitis C Drug Market Share by Country (2018-2029)
Figure 39. Mexico Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Chronic Hepatitis C Drug Market Share by Country (2018-2029)
Figure 43. Turkey Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Chronic Hepatitis C Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Gilead Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 46. Bristol Myers Squibb Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 47. AbbVie Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 51. Kawin Technology Revenue Growth Rate in Chronic Hepatitis C Drug Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Food Grade FIBC Bulk Bags Market Research Report 2025
Jan 09, 25
Global Standard FIBC Market Research Report 2025
Jan 09, 25
Global Mammoplasty Retractors Market Research Report 2025
Jan 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232